Nowadays, there's promising research suggesting that LSD could have a therapeutic effect and be used to treat addiction, depression, and anxiety in the future, although LSD is still considered a Schedule I drug (which the Drug Enforcement Agency defines as having "no currently accepted medical use and a high potential for abuse")
Integrated treatment approaches that combine pharmacological aids (such as nicotine replacement therapy, varenicline, or bupropion) with cognitive-behavioral therapy (CBT) have been shown to be particularly effective for individuals with co-occurring mood symptoms. Furthermore, systematic screening for anxiety and depression in tobacco cessation settings can identify individuals who may benefit from additional psychological support
Fifteen years later, Philip Morris, whose brands include Marlboro and Chesterfield, generates a quarter of its $28 billion in sales from smoke-free products, and aims to boost that share to more than half by 2025
"The Rhodes to a new era in Oklahoma City"
Instead, the non-smokers right to fresh indoor air takes precedence